164 related articles for article (PubMed ID: 27753794)
21. Immunogenicity of 20 micrograms of recombinant DNA hepatitis B vaccine in healthy neonates: a comparison of three different vaccination schemes.
del Canho R; Grosheide PM; Voogd M; Huisman WM; Heijtink RA; Schalm SW
J Med Virol; 1993 Sep; 41(1):30-4. PubMed ID: 8228934
[TBL] [Abstract][Full Text] [Related]
22. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.
Gilbert CL; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
Hum Vaccin; 2011 Dec; 7(12):1336-42. PubMed ID: 22185811
[TBL] [Abstract][Full Text] [Related]
23. A comparative trial of two surface subunit recombinant hepatitis B vaccines vs a surface and PreS subunit vaccine for immunization of healthy adults.
Eyigün CP; Yilmaz S; Gül C; Sengül A; Hacibektasoglu A; Van Thiel DH
J Viral Hepat; 1998 Jul; 5(4):265-9. PubMed ID: 9751013
[TBL] [Abstract][Full Text] [Related]
24. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy infants.
Vesikari T; Martin JC; Liss CL; Liska V; Schödel FP; Bhuyan PK
Pediatr Infect Dis J; 2011 Jul; 30(7):e109-13. PubMed ID: 21552183
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B vaccine alone may be enough for preventing hepatitis B virus transmission in neonates of HBsAg (+)/HBeAg (-) mothers.
Lu Y; Liang XF; Wang FZ; Yan L; Li RC; Li YP; Zhu FC; Zhai XJ; Li J; Zhuang H
Vaccine; 2017 Jan; 35(1):40-45. PubMed ID: 27894717
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of HBV vaccine during stated shelf-life.
Gloriani NG; Srinivasa K; Bock HL; Hoet B
Southeast Asian J Trop Med Public Health; 2010 Jul; 41(4):876-82. PubMed ID: 21073062
[TBL] [Abstract][Full Text] [Related]
27. A randomized, controlled clinical trial to evaluate the immunogenicity of a PreS/S hepatitis B vaccine Sci-B-Vac™, as compared to Engerix B
Elhanan E; Boaz M; Schwartz I; Schwartz D; Chernin G; Soetendorp H; Gal Oz A; Agbaria A; Weinstein T
Clin Exp Nephrol; 2018 Feb; 22(1):151-158. PubMed ID: 28456864
[TBL] [Abstract][Full Text] [Related]
28. Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of age.
Halperin SA; Ward B; Cooper C; Predy G; Diaz-Mitoma F; Dionne M; Embree J; McGeer A; Zickler P; Moltz KH; Martz R; Meyer I; McNeil S; Langley JM; Martins E; Heyward WL; Martin JT
Vaccine; 2012 Mar; 30(15):2556-63. PubMed ID: 22326642
[TBL] [Abstract][Full Text] [Related]
29. Comparison of two hepatitis B vaccines (GeneVac-B and Engerix-B) in healthy infants in India.
Shivananda ; Somani V; Srikanth BS; Mohan M; Kulkarni PS
Clin Vaccine Immunol; 2006 Jun; 13(6):661-4. PubMed ID: 16760324
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults.
Halperin SA; Dobson S; McNeil S; Langley JM; Smith B; McCall-Sani R; Levitt D; Nest GV; Gennevois D; Eiden JJ
Vaccine; 2006 Jan; 24(1):20-6. PubMed ID: 16198027
[TBL] [Abstract][Full Text] [Related]
31. Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus.
Van Der Meeren O; Peterson JT; Dionne M; Beasley R; Ebeling PR; Ferguson M; Nissen MD; Rheault P; Simpson RW; De Ridder M; Crasta PD; Miller JM; Trofa AF
Hum Vaccin Immunother; 2016 Aug; 12(8):2197-2203. PubMed ID: 27123743
[TBL] [Abstract][Full Text] [Related]
32. Occult HBV Infection in Immunized Neonates Born to HBsAg-Positive Mothers: A Prospective and Follow-Up Study.
Lu Y; Liu YL; Nie JJ; Liang XF; Yan L; Wang FZ; Zhai XJ; Liu JX; Zhu FC; Chang ZJ; Li J
PLoS One; 2016; 11(11):e0166317. PubMed ID: 27835694
[TBL] [Abstract][Full Text] [Related]
33. Rapid immunization effects of a new type of 60 μg hepatitis B vaccine compared with traditional 20 μg hepatitis B vaccines in adults.
Wang H; Cai B; Rao D; Liu M; Li Y; Liang X; Cui F; Zhang G; Wang F; Pang X; Nie L; Qiu Q; Wu J; Li L; Huang F; Zhang W
Hum Vaccin Immunother; 2016 Nov; 12(11):2921-2926. PubMed ID: 27648684
[TBL] [Abstract][Full Text] [Related]
34. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity.
del Canho R; Grosheide PM; Mazel JA; Heijtink RA; Hop WC; Gerards LJ; de Gast GC; Fetter WP; Zwijneberg J; Schalm SW
Vaccine; 1997 Oct; 15(15):1624-30. PubMed ID: 9364693
[TBL] [Abstract][Full Text] [Related]
35. Duration of protection after infant hepatitis B vaccination series.
Middleman AB; Baker CJ; Kozinetz CA; Kamili S; Nguyen C; Hu DJ; Spradling PR
Pediatrics; 2014 Jun; 133(6):e1500-7. PubMed ID: 24843060
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus transmission pattern and vaccination efficiency in Uzbekistan.
Avazova D; Kurbanov F; Tanaka Y; Sugiyama M; Radchenko I; Ruziev D; Musabaev E; Mizokami M
J Med Virol; 2008 Feb; 80(2):217-24. PubMed ID: 18098129
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity and safety of a Haemophilus influenzae B (Hib)-hepatitis B vaccine with a modified process hepatitis B component administered with concomitant pneumococcal conjugate vaccine to infants.
Lee AW; Vesikari T; Gilbert CL; Klopfer SO; Schödel FP; Bhuyan PK
Vaccine; 2011 Oct; 29(45):7942-8. PubMed ID: 21875633
[TBL] [Abstract][Full Text] [Related]
38. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
[TBL] [Abstract][Full Text] [Related]
39. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
Yin YZ; Zhou J; Zhang PZ; Hou HY
Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
[TBL] [Abstract][Full Text] [Related]
40. A Randomized Controlled Trial to Evaluate a Potential Hepatitis B Booster Vaccination Strategy Using Combined Hepatitis A and B Vaccine.
Li F; Hu Y; Zhou Y; Chen L; Xia W; Song Y; Tan Z; Gao L; Yang Z; Zeng G; Han X; Li J; Li J
Pediatr Infect Dis J; 2017 May; 36(5):e157-e161. PubMed ID: 28060048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
